Showing results (361-370 of 374) with videos related to
Sort By:
Pageof 38
Journal of Crohn'S & Colitis|December 22, 2010
Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991-2002: Incidence, diagnostic delay, and seasonal variations in onset of symptomsMariëlle J L Romberg-Camps, Martine A M Hesselink-van de Kruijs, Leo J Schouten, et al.Journal of Cellular and Molecular Medicine|September 17, 2014
Delayed cutaneous wound closure in HO-2 deficient mice despite normal HO-1 expressionDitte M S Lundvig, Alwin Scharstuhl, Niels A J Cremers, et al.Journal of Inherited Metabolic Disease|February 8, 2020
Safety of drug use in patients with a primary mitochondrial disease: An international Delphi-based consensusMaaike C De Vries, David A Brown, Mitchell E Allen, et al.Archives of Toxicology|May 13, 2026
Contribution of dermal ethanol absorption during laboratory-controlled high-frequency use of alcohol-based hand rubs followed by glove usePaul T J Scheepers, Kirsten Lassing, Martien H F Graumans, et al.Plos One|June 21, 2024
Effects of allopurinol and febuxostat on uric acid transport and transporter expression in human umbilical vein endothelial cellsKarel H van der Pol, Jan Koenderink, Jeroen J M W van den Heuvel, et al.Molecular Microbiology|March 19, 2016
Vital and dispensable roles of Plasmodium multidrug resistance transporters during blood- and mosquito-stage developmentSanna R Rijpma, Maarten van der Velden, Takeshi Annoura, et al.Journal of Pharmaceutical Sciences|February 5, 2021
Implementation of a Human Renal Proximal Tubule on a Chip for Nephrotoxicity and Drug Interaction StudiesMarianne K Vormann, Jelle Vriend, Henriëtte L Lanz, et al.Journal of Clinical Pharmacology|September 23, 2021
Prediction of Moxifloxacin Concentrations in Tuberculosis Patient Populations by Physiologically Based Pharmacokinetic ModelingCarlijn H C Litjens, Laurens F M Verscheijden, Celine Bolwerk, et al.Cellular Microbiology|September 3, 2015
Multidrug ATP-binding cassette transporters are essential for hepatic development of Plasmodium sporozoitesSanna R Rijpma, Maarten van der Velden, Maria González-Pons, et al.Journal of Crohn'S & Colitis|June 13, 2023
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI TrialFenna M Jansen, Reinier C A van Linschoten, Wietske Kievit, et al.Pageof 38